AcelRx Pharmaceuticals, Inc. (ACRX) Granted First U.S. Patent Relating to Sublingual Sufentanil NanoTabs
AcelRx Pharmaceuticals announced today that the U.S. Patent and Trademark Office (USPTO) has issued AcelRx Patent Number 8,202,535, titled “Small-Volume…